Healthcare provider profile · identity verified

Nicholas A Giuliani, MD

Family Practice · GLEN MILLS, PA · NPI 1053428938

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	591	174
Amlodipine Besylate	Amlodipine Besylate	359	110
Levothyroxine Sodium	Levothyroxine Sodium	290	85
Lorazepam	Lorazepam	231	52
Omeprazole	Omeprazole	227	72
Lisinopril	Lisinopril	215	61
Losartan Potassium	Losartan Potassium	214	59
Clonazepam	Clonazepam	197	29
Metformin Hcl	Metformin Hcl	184	50
Metoprolol Succinate	Metoprolol Succinate	182	59
Simvastatin	Simvastatin	173	48
Gabapentin	Gabapentin	159	44
Escitalopram Oxalate	Escitalopram Oxalate	153	42
Pantoprazole Sodium	Pantoprazole Sodium	147	45
Zolpidem Tartrate	Zolpidem Tartrate	138	29
Rosuvastatin Calcium	Rosuvastatin Calcium	129	45
Sertraline Hcl	Sertraline Hcl	126	35
Hydrochlorothiazide	Hydrochlorothiazide	122	41
Tamsulosin Hcl	Tamsulosin Hcl	92	34
Furosemide	Furosemide	90	30
Allopurinol	Allopurinol	88	25
Famotidine	Famotidine	85	26
Trazodone Hcl	Trazodone Hcl	83	25
Alprazolam	Alprazolam	81	14
Fluticasone Propionate	Fluticasone Propionate	80	26
Tramadol Hcl	Tramadol Hcl	80	22
Alendronate Sodium	Alendronate Sodium	66	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	20
Glimepiride	Glimepiride	63	17
Oxycodone Hcl	Oxycodone Hcl	58	suppressed
Diazepam	Diazepam	56	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	16
Azithromycin	Azithromycin	54	47
Metoprolol Tartrate	Metoprolol Tartrate	51	19
Ozempic	Semaglutide	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	50	16
Citalopram Hbr	Citalopram Hydrobromide	48	13
Esomeprazole Magnesium	Esomeprazole Magnesium	48	16
Potassium Chloride	Potassium Chloride	48	16
Albuterol Sulfate Hfa	Albuterol Sulfate	47	26
Duloxetine Hcl	Duloxetine Hcl	46	13
Eliquis	Apixaban	46	15
Celecoxib	Celecoxib	45	suppressed
Meloxicam	Meloxicam	45	15
Methylprednisolone	Methylprednisolone	45	39
Pioglitazone Hcl	Pioglitazone Hcl	44	13
Ezetimibe	Ezetimibe	41	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	33
Metformin Hcl Er	Metformin Hcl	39	14
Montelukast Sodium	Montelukast Sodium	39	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	39	suppressed
Amoxicillin	Amoxicillin	38	30
Xarelto	Rivaroxaban	38	12
Bupropion Xl	Bupropion Hcl	36	14
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Finasteride	Finasteride	31	12
Prednisone	Prednisone	31	22
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Atenolol	Atenolol	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Ramipril	Ramipril	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	20
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	16
Ondansetron Odt	Ondansetron	20	14
Aripiprazole	Aripiprazole	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	19	suppressed
Cephalexin	Cephalexin	19	13
Doxepin Hcl	Doxepin Hcl	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Valsartan	Valsartan	19	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Felodipine Er	Felodipine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Methimazole	Methimazole	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Testosterone	Testosterone	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Keppra	Levetiracetam	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Tegretol	Carbamazepine	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Oxazepam	Oxazepam	11	suppressed
Repaglinide	Repaglinide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error